Recursion Pharma

Stock Soars on Oct 20 Amid Wild October Trading Recursion’s stock is on a rollercoaster ride this month. Early on October 20, RXRX surged ~16–18%, hitting intraday highs near $6.8 benzinga.com. The rally comes after shares slid 7.9% on Friday to $5.86 stockinvest.us, as traders took profits following a mid-October run-up. Broader market tailwinds helped – the Nasdaq Composite was up ~1% on Monday – and several biotech peers also soared on news (for example, Replimune jumped 100%+ on an FDA decision, and Celcuity climbed 46% on trial data) benzinga.com. Recursion’s sharp rebound Monday recoups some losses from last week’s